Literature DB >> 3137672

Use of Rh positive blood in emergency situations.

P J Schmidt1, G F Leparc, C T Samia.   

Abstract

The emergency blood needs of 449 patients were met by supplying 1,717 uncrossmatched units of either red blood cells (RBC) type specific Whole Blood or group O RBC. The RBC were all Rh positive, and 601 units were transfused to 262 untyped patients. None of the patients presented with anti-Rh antibodies. Only 20 patients who were Rh negative received group O Rh positive RBC, and most of these patients were male. There were no acute hemolytic reactions or sensitizations of young females. Group O Rh positive RBC is our first choice to support patients with trauma who cannot wait for type specific or crossmatched blood. Those who do survive the emergency conditions can be reverted to blood of their own type without problem. Acceptance of Rh positive emergency transfusions by physicians giving emergency care can prevent unbalanced shortages in a regional blood supply system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137672

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  3 in total

1.  Unmatched Type O RhD+ Red Blood Cells in Multiple Injured Patients.

Authors:  Sabine Flommersfeld; Carsten Mand; Christian A Kühne; Gregor Bein; Steffen Ruchholtz; Ulrich J Sachs
Journal:  Transfus Med Hemother       Date:  2018-03-07       Impact factor: 3.747

2.  Delayed gastric emptying in critical illness: is enhanced enterogastric inhibition with cholecystokinin and peptide YY involved?

Authors:  Andrew J W Samis
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

3.  Safety of Uncrossmatched ABO-Compatible RBCs in Alloimmunized Patients with Bleeding: Data from Two Decades: Results of a Systematic Analysis in 6,109 Patients.

Authors:  Frauke Ringel; Helge Schoenfeld; Said El Bali; Jalid Sehouli; Claudia Spies; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2021-12-08       Impact factor: 4.040

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.